Acceptance of a reusable self-injection device for recombinant human growth hormone: final data from a questionnaire-based, cross-sectional, international, multicenter, observational study in pediatric patients
Dirk Schnabel,1 Carl-Joachim Partsch,2 Muriel Houang,3 Sarah Ehtisham,4 Helen Johnstone,5 Markus Zabransky,6 Wieland Kiess7 1Pediatric Endocrinology, Center for Chronic Sick Children, Otto-Heubner-Centrum für Kinder- und Jugendmedizin, Charite, University Medicine, Berlin, Germany; 2Endokri...
Guardado en:
Autores principales: | Schnabel D, Partsch CJ, Houang M, Ehtisham S, Johnstone H, Zabransky M, Kiess W |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9ab1a67b773440529f161b47db390357 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Acceptability of the reusable SurePal™ self-injection device for Omnitrope® among pediatric patients: results from a questionnaire-based, cross-sectional, multicenter observational study
por: Partsch CJ, et al.
Publicado: (2015) -
Computed tomography and magnetic resonance imaging contrast media injectors: technical feature review – what is really needed?
por: Friebe M
Publicado: (2016) -
Enteral feeding pumps: efficacy, safety, and patient acceptability
por: White H, et al.
Publicado: (2014) -
Development of devices for self-injection: using tribological analysis to optimize injection force
por: Lange J, et al.
Publicado: (2016) -
Design evolution enhances patient compliance for low-intensity pulsed ultrasound device usage
por: Pounder NM, et al.
Publicado: (2016)